HNRNPMP2

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, HNRNPMP2 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated HNRNPMP2 data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher HNRNPMP2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated HNRNPMP2 expression acts as an unfavorable survival marker, although some lineages such as OV show a favorable association.

KICH, CESC, and OV are the cancer types where HNRNPMP2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
KICHDFSTertileAll0.0530.924<.001108view →
CESCDFSTertileII,III,IV0.0530.786<.00190view →
OVOSTertileIII,IV0.9340.671.01442view →
MESODFSTertileAll0.1210.368.0449view →
Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

HNRNPMP2–KICH (DFS)

Kaplan–Meier survival curve for HNRNPMP2 RNA-high vs -low samples in KICH.

Open the KICH breakdown →

Exploration